IBEX Ltd (IBEX)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at IBEX Ltd.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 4 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 35.30 $ — 57% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 4.2% failed
- More than 10% revenue growth is expected for the coming year 6.1% failed
- Share count grows by less than 3% a year -5.7% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 14.7% failed
- Gross margin at 40% or higher and without meaningful erosion 30.9% failed
- Goodwill from acquisitions does not grow faster than revenue 4.3% passed
- Net debt below twice EBITDA 0.8 x EBITDA passed
- Operating cash flow covers the profits of the last three years 21 m passed
- Return on capital at 15% or higher, or up versus two years ago 24.1% passed
- Insiders hold at least 10% or are net buyers 7.1% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 6.2% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 1
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 06/30/2027 | 3.63 | 3.53 – 3.72 | 679 | 3.0% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.85 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.69 | 52.60 | 141 | 6.10 | 6.60 | 1 | -3 |
| 2025: Q1 | 0.78 | 1.50 | 141 | 11.00 | 7.40 | 9 | 4 |
| 2025: Q2 | 0.72 | -2.50 | 147 | 18.20 | 6.50 | 28 | 23 |
| 2025: Q3 | 0.90 | 59.90 | 151 | 16.50 | 8.00 | 16 | 8 |
| 2025: Q4 | 0.91 | 31.80 | 164 | 16.70 | 7.40 | 7 | -5 |
| 2026: Q1 | 1.00 | 27.30 | 164 | 16.80 | 8.10 | 12 | 7 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 323 | 9 | 2 | 0.09 | 3 | 16 | 138 |
| 2017 | 334 | -2 | -9 | -0.51 | 7 | 29 | 152 |
| 2018 | 342 | -18 | -16 | -0.90 | -6 | 28 | 157 |
| 2019 | 368 | 7 | -5 | -0.26 | 2 | 9 | 188 |
| 2020 | 405 | 20 | 8 | 0.44 | 52 | 16 | 195 |
| 2021 | 443 | 17 | 13 | 0.71 | 26 | 81 | 274 |
| 2022 | 493 | 21 | 21 | 1.15 | 40 | 113 | 294 |
| 2023 | 523 | 40 | 32 | 1.67 | 42 | 150 | 293 |
| 2024 | 509 | 39 | 34 | 1.84 | 36 | 166 | 294 |
| 2025 | 558 | 47 | 37 | 2.34 | 46 | 134 | 273 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
IBEX Limited bietet durchgängige, technologiegestützte Lösungen für den gesamten Customer-Lifecycle in den USA und international an. Das Produkt- und Dienstleistungsportfolio umfasst ibex Connect mit Kundenservice, technischem Support, Umsatzgenerierung und weiteren wertschöpfenden Out…
| Employees | 36,000 |
|---|---|
| Headquarters | Washington, DC |
| Address | 1717 Pennsylvania Avenue NW, 20006 Washington, United States |
| Phone | 202 580 6200 |
| Website | ibex.co |
| IPO Date | 7. Aug 2020 |
| ISIN | BMG4690M1010 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Robert T. Dechant | CEO & Director | 1962 |
| Taylor C. Greenwald | Chief Financial Officer | 1968 |
| David Afdahl | Chief Operating Officer | 1974 |
| Bruce N. Dawson | Chief Sales & Client Services Officer | 1964 |
| Julie M. Casteel | Chief Marketing & Strategic Accounts Officer | 1962 |
| Michael Ringman | Chief Technology Officer | 1972 |
| Christy O'Connor | Chief Legal Officer & Assistant Corporate Secretary | 1969 |
| Paul Inson | Chief People Officer | 1964 |
| Carl O'Neil | EVP & President of Augment | 1979 |
| Greg Rajchel | Executive Vice President of Commercial & Client Operations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 20. Jul 2026 | Darwal Michael Joseph | Chief AI & Digital Officer | Other | 200 | 35.07 | 7,014 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.